Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2024 Filed Jan 18, 2024 23:26 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,666 | $18.42 | $30,687.72 |
DisclosureSEC source: 0001714899-24-000041 · wk-form4_1705620357.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,041 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $18.13 to $18.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 4,216 RSUs. Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 01:18 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 4,668 | $19.02 | $88,785.36 |
DisclosureSEC source: 0001714899-24-000040 · wk-form4_1705108724.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,794 F1 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $18.61 to $19.57 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 136,904 RSUs. F4 · balance_after: Reflects 15,558 shares previously disclosed as held indirectly; but have been determined to be held directly. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 22:28 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 7,818 | $19.78 | $154,640.04 |
DisclosureSEC source: 0001714899-24-000039 · wk-form4_1705012085.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,268,363 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.60 to $20.02 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| January 05, 2024 Filed Jan 10, 2024 00:33 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 17,483 | $19.43 | $339,694.69 |
DisclosureSEC source: 0001714899-24-000035 · wk-form4_1704846791.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,276,181 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.36 to $19.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 51,060 restricted stock units held by the Reporting Person. F4 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| January 05, 2024 Filed Jan 10, 2024 00:34 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 9,972 | $19.43 | $193,755.96 |
DisclosureSEC source: 0001714899-24-000036 · wk-form4_1704846835.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 539,307 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.36 to $19.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 25,530 RSUs held by the Reporting Person. F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| January 05, 2024 Filed Jan 10, 2024 00:35 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 9,972 | $19.43 | $193,755.96 |
DisclosureSEC source: 0001714899-24-000038 · wk-form4_1704846922.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 198,777 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.35 to $19.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 25,530 RSUs held by the Reporting Person. F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 05, 2024 Filed Jan 10, 2024 00:34 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 3,208 | $19.43 | $62,331.44 |
DisclosureSEC source: 0001714899-24-000037 · wk-form4_1704846873.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,591 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.37 to $19.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 24,002 RSUs. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:56 UTC |
Watts Ryan J.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 268,560 | $0.00 Strike: $20.33 | $0.00 |
DisclosureSEC source: 0001714899-24-000008 · wk-form4_1704495377.xml · derivative · entry 3 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,560 Underlying: Common Stock · 268,560 shares Expires 2034-01-02 F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2025, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:56 UTC |
Watts Ryan J.Director · President and CEO
|
GrantCommon Stock | 89,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000008 · wk-form4_1704495377.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,957 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2025 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · balance_after: Includes 221,897 RSU's as of January 4, 2024. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:57 UTC |
Schuth Alexander O.COFO and Secretary
|
GrantStock Option (right to buy) · Derivative | 161,160 | $0.00 Strike: $20.33 | $0.00 |
DisclosureSEC source: 0001714899-24-000010 · wk-form4_1704495454.xml · derivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,160 Underlying: Common Stock · 161,160 shares Expires 2034-01-02 F5 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2025, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:57 UTC |
Schuth Alexander O.COFO and Secretary
|
GrantCommon Stock | 53,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000010 · wk-form4_1704495454.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,157 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2025 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · balance_after: Includes 136,721 RSU's as of January 4, 2024. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:57 UTC |
Ho CaroleChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 161,160 | $0.00 Strike: $20.33 | $0.00 |
DisclosureSEC source: 0001714899-24-000009 · wk-form4_1704495415.xml · derivative · entry 4 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,160 Underlying: Common Stock · 161,160 shares Expires 2034-01-02 F6 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2025, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:57 UTC |
Ho CaroleChief Medical Officer
|
GrantCommon Stock | 53,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000009 · wk-form4_1704495415.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,434 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2025 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · balance_after: Includes 136,904 RSU's as of January 4, 2024. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 00:30 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,666 | $23.39 | $38,967.74 |
DisclosureSEC source: 0001714899-23-000150 · wk-form4_1702945827.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,707 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023. F2 · balance_after: Includes 4,216 RSUs. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 23:14 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,666 | $19.13 | $31,870.58 |
DisclosureSEC source: 0001714899-23-000147 · wk-form4_1700176428.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,373 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023. F2 · balance_after: Includes 4,216 RSUs. Read SEC document |
| October 16, 2023 Filed Oct 18, 2023 20:44 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,666 | $20.66 | $34,419.56 |
DisclosureSEC source: 0001714899-23-000139 · wk-form4_1697661869.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,039 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023. F2 · balance_after: Includes 4,216 RSUs. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 20:45 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 40 | $24.35 | $974.00 |
DisclosureSEC source: 0001714899-23-000138 · wk-form4_1695156311.xml · nonDerivative · entry 2 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,705 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023. F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.32 to $24.37 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F4 · balance_after: Includes 4,216 RSUs. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 20:45 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,626 | $23.60 | $38,373.60 |
DisclosureSEC source: 0001714899-23-000138 · wk-form4_1695156311.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,745 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.28 to $24.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:36 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,522 | $23.17 | $58,434.74 |
DisclosureSEC source: 0001714899-23-000137 · wk-form4_1692999400.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 518,989 F1 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.87 to $23.36 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:30 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,522 | $23.22 | $58,560.84 |
DisclosureSEC source: 0001714899-23-000136 · wk-form4_1692999010.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 182,809 F1 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted March 30, 2022. F2 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 20:32 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 2,309 | $22.59 | $52,160.31 |
DisclosureSEC source: 0001714899-23-000133 · wk-form4_1692822729.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,242,604 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: . The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.50 to $23.00 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 5,000 restricted stock units held by the Reporting Person. F4 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 20:33 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,478 | $22.59 | $55,978.02 |
DisclosureSEC source: 0001714899-23-000134 · wk-form4_1692822802.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 521,511 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.49 to $23.00 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 5,000 RSUs held by the Reporting Person. F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 20:34 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,478 | $22.60 | $56,002.80 |
DisclosureSEC source: 0001714899-23-000135 · wk-form4_1692822872.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 185,331 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.55 to $23.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 5,000 RSUs held by the Reporting Person. F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 20:31 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 1,419 | $22.60 | $32,069.40 |
DisclosureSEC source: 0001714899-23-000132 · wk-form4_1692822662.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,799 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.51 to $22.99 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 31,502 RSUs. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 22:42 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,666 | $24.30 | $40,483.80 |
DisclosureSEC source: 0001714899-23-000126 · wk-form4_1692312142.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,371 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.07 to $24.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 4,216 RSUs. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 22:19 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,772 | $23.67 | $65,613.24 |
DisclosureSEC source: 0001714899-23-000124 · wk-form4_1692224345.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 518,989 F1 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.58 to $23.80 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 22:20 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,768 | $23.79 | $65,850.72 |
DisclosureSEC source: 0001714899-23-000125 · wk-form4_1692224392.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 182,809 F1 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted March 30, 2023. F2 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 21:13 UTC |
Watts Ryan J.Director · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,526 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001714899-23-000123 · wk-form4_1692047595.xml · derivative · entry 4 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,118,091 Underlying: Common Stock · 2,526 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 21:13 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 2,526 | $25.03 | $63,225.78 |
DisclosureSEC source: 0001714899-23-000123 · wk-form4_1692047595.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,239,913 F3 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted August 18, 2022. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $25.00 to $25.11 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 21:13 UTC |
Watts Ryan J.Director · President and CEO
|
Exercise / conversionCommon Stock | 2,526 | $0.68 | $1,717.68 |
DisclosureSEC source: 0001714899-23-000123 · wk-form4_1692047595.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,242,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Exercised shares were issued to the Watts Family 2015 Trust. F2 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 21:11 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,853 | $24.18 | $68,985.54 |
DisclosureSEC source: 0001714899-23-000121 · wk-form4_1692047483.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 521,761 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: . The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.99 to $24.35 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 5,625 RSUs held by the Reporting Person. F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 21:12 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,857 | $24.15 | $68,996.55 |
DisclosureSEC source: 0001714899-23-000122 · wk-form4_1692047539.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 185,577 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.99 to $24.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 5,625 RSUs held by the Reporting Person. F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 21:10 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 9,702 | $30.01 | $291,157.02 |
DisclosureSEC source: 0001714899-23-000109 · wk-form4_1689801007.xml · nonDerivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 518,989 F3 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.04 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 21:10 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001714899-23-000109 · wk-form4_1689801007.xml · derivative · entry 5 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,937 Underlying: Common Stock · 10,000 shares Expires 2027-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vested monthly thereafter. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 21:10 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 10,000 | $29.60 | $296,000.00 |
DisclosureSEC source: 0001714899-23-000109 · wk-form4_1689801007.xml · nonDerivative · entry 2 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 528,691 F3 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.33 to $29.94 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 21:10 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionCommon Stock | 10,000 | $5.28 | $52,800.00 |
DisclosureSEC source: 0001714899-23-000109 · wk-form4_1689801007.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 538,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Exercised shares were issued to the Schuth Family Trust. F2 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 21:09 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,666 | $29.60 | $49,313.60 |
DisclosureSEC source: 0001714899-23-000108 · wk-form4_1689800946.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,037 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.35 to $29.94 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 4,216 RSUs. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 21:21 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,114 | $29.98 | $33,397.72 |
DisclosureSEC source: 0001714899-23-000107 · wk-form4_1688160091.xml · nonDerivative · entry 2 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,703 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023. F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.85 to $30.22 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F4 · balance_after: Includes 4,216 RSUs. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 21:21 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 552 | $29.55 | $16,311.60 |
DisclosureSEC source: 0001714899-23-000107 · wk-form4_1688160091.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,817 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.85 to $29.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 22:28 UTC |
Watts Ryan J.Director · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001714899-23-000105 · wk-form4_1687300068.xml · derivative · entry 4 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,120,617 Underlying: Common Stock · 50,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 22:28 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 50,000 | $31.40 | $1,570,000.00 |
DisclosureSEC source: 0001714899-23-000105 · wk-form4_1687300068.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,239,913 F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted February 10, 2023. F1 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 22:28 UTC |
Watts Ryan J.Director · President and CEO
|
Exercise / conversionCommon Stock | 50,000 | $0.68 | $34,000.00 |
DisclosureSEC source: 0001714899-23-000105 · wk-form4_1687300068.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,289,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:08 UTC |
Thornberry NancyDirector
|
GrantStock Option (right to buy) · Derivative | 12,649 | $0.00 Strike: $30.92 | $0.00 |
DisclosureSEC source: 0001714899-23-000101 · wk-form4_1686002897.xml · derivative · entry 2 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,649 Underlying: Common Stock · 12,649 shares Expires 2033-06-01 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:08 UTC |
Thornberry NancyDirector
|
GrantCommon Stock | 4,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-23-000101 · wk-form4_1686002897.xml · nonDerivative · entry 1 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,713 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,472 unvested RSUs. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:07 UTC |
Krognes Steve E.Director
|
GrantStock Option (right to buy) · Derivative | 12,649 | $0.00 Strike: $30.92 | $0.00 |
DisclosureSEC source: 0001714899-23-000100 · wk-form4_1686002853.xml · derivative · entry 3 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,649 Underlying: Common Stock · 12,649 shares Expires 2033-06-01 F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:07 UTC |
Krognes Steve E.Director
|
GrantCommon Stock | 4,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-23-000100 · wk-form4_1686002853.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,218 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 36,502 unvested RSUs. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:06 UTC |
Tessier-Lavigne MarcDirector
|
GrantStock Option (right to buy) · Derivative | 12,649 | $0.00 Strike: $30.92 | $0.00 |
DisclosureSEC source: 0001714899-23-000099 · wk-form4_1686002790.xml · derivative · entry 5 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,649 Underlying: Common Stock · 12,649 shares Expires 2033-06-01 F6 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:06 UTC |
Tessier-Lavigne MarcDirector
|
GrantCommon Stock | 4,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-23-000099 · wk-form4_1686002790.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,874,572 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 4,216 unvested RSUs. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:05 UTC |
Klein Peter SDirector
|
GrantStock Option (right to buy) · Derivative | 12,649 | $0.00 Strike: $30.92 | $0.00 |
DisclosureSEC source: 0001714899-23-000098 · wk-form4_1686002730.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,649 Underlying: Common Stock · 12,649 shares Expires 2033-06-01 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:05 UTC |
Klein Peter SDirector
|
GrantCommon Stock | 4,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-23-000098 · wk-form4_1686002730.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,529 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 4,216 unvested RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.